Analyst Coverage
Oryzon Genomics, S.A. is currently followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Oryzon Genomics, S.A.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oryzon Genomics, S.A. or its management. Oryzon Genomics, S.A. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Publicy available reports
-
Edison Group (UK)AnalystJonas Peciulis1 January 20201 October 20191 April 20191 November 20181 July 20181 December 20171 May 20171 March 20171 December 20161 November 20161 March 2016
-
Estrategias de Inversión (ES)AnalystMaría Mira1 November 20191 September 20191 February 2019
-
Invest Securities (FR)AnalystThibaut Voglimacci - Stephanopoli1 September 20191 May 20191 November 2018
-
Luis Navia (ES)AnalystLuis Navia31 July 20201 March 20201 November 20191 February 20191 November 20181 September 20181 November 20171 September 20171 November 20161 September 2016
-
ROTH Capital Partners (US)AnalystJonathan Aschoff17 September 20208 July 20201 April 20201 February 20201 July 20191 March 20191 June 20191 September 20181 May 20181 April 2018
Reports only available to clients and partners of the analyst company
-
Jefferies (US)
AnalystLucy Codrington et al -
Rx Securities (UK)
AnalystJoseph Hedden